These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21315181)

  • 1. How to compute which genes control drug resistance dynamics.
    Guo Y; Luo J; Wang J; Wang Y; Wu R
    Drug Discov Today; 2011 Apr; 16(7-8):339-44. PubMed ID: 21315181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo estimates of natural variation in HIV infection.
    Heffernan JM; Wahl LM
    J Theor Biol; 2005 Sep; 236(2):137-53. PubMed ID: 16005307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilocus linkage disequilibrium mapping of epistatic quantitative trait loci that regulate HIV dynamics: a simulation approach.
    Wu S; Yang J; Wu R
    Stat Med; 2006 Nov; 25(22):3826-49. PubMed ID: 16435340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probability of resistance evolution for exponentially growing virus in the host.
    Haeno H; Iwasa Y
    J Theor Biol; 2007 May; 246(2):323-31. PubMed ID: 17306832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A statistical model to analyse quantitative trait locus interactions for HIV dynamics from the virus and human genomes.
    Wang Z; Hou W; Wu R
    Stat Med; 2006 Feb; 25(3):495-511. PubMed ID: 16013038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
    Huang Y
    Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic resistance tests for the management of patients with viro-immunological discordant response to highly active antiretroviral therapy.
    Moroni M
    Scand J Infect Dis Suppl; 2003; 106():85-7. PubMed ID: 15000593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of distributed life cycles on the dynamics of viral infections.
    Campos D; Méndez V; Fedotov S
    J Theor Biol; 2008 Sep; 254(2):430-8. PubMed ID: 18573261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
    Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
    J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on antiviral drug development.
    Wainberg MA
    Antiviral Res; 2009 Jan; 81(1):1-5. PubMed ID: 18948140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamical model of human immune response to influenza A virus infection.
    Hancioglu B; Swigon D; Clermont G
    J Theor Biol; 2007 May; 246(1):70-86. PubMed ID: 17266989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential equation model for functional mapping of a virus-cell dynamic system.
    Luo J; Hager WW; Wu R
    J Math Biol; 2010 Jul; 61(1):1-15. PubMed ID: 19685244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ; Wahl LM
    Bull Math Biol; 2005 Jul; 67(4):783-813. PubMed ID: 15893553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic stochastic models for viral infection within a host.
    Vidurupola SW; Allen LJ
    Math Biosci Eng; 2012 Oct; 9(4):915-35. PubMed ID: 23311428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiparametric functional mapping of quantitative trait loci governing long-term HIV dynamics.
    Wu S; Yang J; Wu R
    Bioinformatics; 2007 Jul; 23(13):i569-76. PubMed ID: 17646344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.